The United Graduate School of Agricultural Sciences, Tottori University, Tottori 680-8550, Japan.
Department of Organ Pathology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan.
Int J Mol Sci. 2021 Jan 14;22(2):800. doi: 10.3390/ijms22020800.
Raman spectroscopy (RS), a non-invasive and label-free method, has been suggested to improve accuracy of cytological and even histopathological diagnosis. To our knowledge, this novel technique tends to be employed without concrete knowledge of molecular changes in cells. Therefore, identification of Raman spectral markers for objective diagnosis is necessary for universal adoption of RS. As a model study, we investigated human mammary epithelial cells (HMEpC) and breast cancer cells (MCF-7) by RS and employed various multivariate analyses (MA) including principal components analysis (PCA), linear discriminant analysis (LDA), and support vector machine (SVM) to estimate diagnostic accuracy. Furthermore, to elucidate the underlying molecular changes in cancer cells, we utilized multivariate curve resolution analysis-alternating least squares (MCR-ALS) with non-negative constraints to extract physically meaningful spectra from complex cellular data. Unsupervised PCA and supervised MA, such as LDA and SVM, classified HMEpC and MCF-7 fairly well with high accuracy but without revealing molecular basis. Employing MCR-ALS analysis we identified five pure biomolecular spectra comprising DNA, proteins and three independent unsaturated lipid components. Relative abundance of lipid 1 seems to be strictly regulated between the two groups of cells and could be the basis for excellent discrimination by chemometrics-assisted RS. It was unambiguously assigned to linoleate rich glyceride and therefore serves as a Raman spectral marker for reliable diagnosis. This study successfully identified Raman spectral markers and demonstrated the potential of RS to become an excellent cytodiagnostic tool that can both accurately and objectively discriminates breast cancer from normal cells.
拉曼光谱(RS)是一种非侵入性和无标记的方法,已被建议用于提高细胞学甚至组织病理学诊断的准确性。据我们所知,这项新技术往往是在对细胞内分子变化缺乏具体了解的情况下使用的。因此,为了普遍采用 RS,有必要确定拉曼光谱的标记物以进行客观诊断。作为模型研究,我们使用 RS 研究了人乳腺上皮细胞(HMEpC)和乳腺癌细胞(MCF-7),并采用了各种多元分析(MA),包括主成分分析(PCA)、线性判别分析(LDA)和支持向量机(SVM),以估计诊断准确性。此外,为了阐明癌细胞中潜在的分子变化,我们利用带非负约束的多元曲线分辨分析-交替最小二乘法(MCR-ALS)从复杂的细胞数据中提取具有物理意义的光谱。无监督 PCA 和有监督 MA,如 LDA 和 SVM,可以很好地分类 HMEpC 和 MCF-7,准确率很高,但没有揭示分子基础。通过 MCR-ALS 分析,我们确定了包含 DNA、蛋白质和三个独立的不饱和脂质成分的五个纯生物分子光谱。两组细胞之间的脂质 1 的相对丰度似乎受到严格调节,并且可能是化学计量学辅助 RS 进行出色区分的基础。它被明确分配给富含亚油酸的甘油酯,因此可作为可靠诊断的拉曼光谱标记物。这项研究成功地确定了拉曼光谱标记物,并证明了 RS 成为一种出色的细胞诊断工具的潜力,它可以准确且客观地区分乳腺癌和正常细胞。